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Abstract
Background: Staphylococcus aureus causes variety of infections in humans and animals worldwide and predominates
in surgical wound infections. This study assessed the antimicrobial potential of the stem bark extract of Chrysophyllum
albidum against an array of vancomycin resistant Staphylococcus aureus (VRSA) isolated from clinical samples.
Methods: The methanolic crude extract of the plant was preliminary screened for the presence of phytochemicals;
after then, the extract was partitioned into n-hexane, chloroform, ethyl acetate and butanol fractions. A range of
concentrations of the plant extract fractions was prepared to assess its antimicrobial potency; the minimum inhibitory
concentrations (MICs); the minimum bactericidal concentrations (MBCs); the rate of killing; the potassium ion leakage
potential and nucleotides leakage ability against the VRSAs.
Results: The phytochemical screening revealed the presence of tannins, alkaloids, flavonoids, saponins, steroids, reducing
sugars and terpenoids as major phytoconstituents resident in the crude plant extract. The two active fractions (n-hexane
and butanol) at a concentration of 10 mg/ml exhibited antibacterial activities with the MIC and MBC values for
the fractions ranged between 0.63–10 mg/ml and 1.25–10 mg/ml respectively. The time kill assay revealed that
the antibacterial action of the two fractions are time and concentration dependent; the n-hexane and butanol
fractions achieved 100 % kill on the test isolates at a concentration of 3 × MIC and 2 × MIC respectively after
120 min of reaction time. Varying amount of potassium ions as well as nucleotides were leaked from the test
cells by n-hexane and butanol fractions.
Conclusions: This study has established the possibility of developing antimicrobial agents of natural origin to manage
possible infection from vancomycin resistant Staphylococcus aureus that are now developing multi-resistance against
many antibiotics.
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Background
Staphylococcus aureus causes variety of infections in
humans and animals worldwide and predominates in
surgical wound infections [1]. This organism causes super-
ficial skin infection and are also responsible for some life-
threatening diseases such as sepsis, respiratory tract and
bloodstream infections [2, 3]. The emergence of vanco-
mycin resistant Staphylococcus aureus is a big concern
that is threatening human’s health globally and has led to
an increase in morbidity and mortality. The abrupt and
continued increase in the use of vancomycin worldwide
resulted in the increasing frequency of VRSA infections in
hospitals [4]. The diseases caused by these multiple-drug
resistant microorganisms are associated with prolonged
hospitalization [5].
Methicillin a derivative of penicillin was used to treat
infection caused by S. aureus after its development of
resistant to penicillin but resistant to methicillin finally
emerged in 1962 [6, 7]. Vancomycin was then considered
the drug of choice for the treatment of infections caused
by S. aureus for many years before the emergence of
VRSA [8]. Emergence of clinical infection due to S. aureus
in a patient in USA with high resistance to vancomycin
was reported in 2002 [9]. Thus, there is an urgent need to
source for antimicrobial agents especially of natural origin
to combat the activities of these pathogens. Emergence of
vancomycin resistance in S. aureus is a global issue, and
thus, this study focused on the potency of stem bark ex-
tract of Chrysophyllum albidium on vancomycin resistant
S. aureus isolated from clinical samples.
Chrysophyllum albidium belongs to the family sapota-
ceae. It is commonly called Agbalumo in Yoruba, Udala in
Igbo and Agbaluba in Hausa languages. This plant is also
referred to as “The white star apple” [10]. Chrysophyllum
albidium is a popular tropical fruit tree and widely distrib-
uted in the low land rain forest zones [11].
In Nigeria this plant is distributed within the south-
western part of the country [12]. Chrysophyllum albidium
is rich in natural antioxidants which promote health [13].
This plant is highly rich in flavonoids, steroids, glyco-
sides and saponins and thus serves as a source of
anti-inflammatory, anti-spasmodic, as well as possesses
diuretic properties [14]. Extracts from seeds and roots of C.
albidium effectively arrested bleeding from fresh wounds
and also promote wound healing [15]. Chrysophyllum albi-
dium leaves are used as emollients and for the treatment of
skin eruptions, diarrhoea and stomach ache [16]. The stem
bark of this plant is used in preparation of decoction for
the treatment of fever and black coated tongues caused by
increase population of bacteria and yeast in the mouth [17].
Leaves extract from C. albidium exhibited antibacterial
activities against S. aureus, Escherichia coli, Salmonella
typhi and Shigella species [18]. Seeds and root extracts ob-
tained from C. albidium exhibited anti-inflammatory, anti-
diarrhoeal and anti-haemorrhoidal [14]. Onyeka [19] dem-
onstrated hypoglycaemic, antioxidant and hepatoprotective
activities of root bark extract of C. albidium in alloxan-
induced diabetic rats.
Methods
Cultures of clinical strains of vancomycin-resistant
Staphylococcus aureus and standard cultures of
Staphylococcus aureus
Various clinical strains of VRSA used for this study were
collected from stock collection of Microbiology Laboratory
of both Obafemi Awolowo University Teaching Hospital,
Ile Ife, Osun State, Nigeria and University College Hospital,
Ibadan, Oyo State, Nigeria. These isolates were first sub
cultured on mannitol salt agar medium (Biolab) to confirm
their purity and strains before use. The isolates were con-
firmed to be true VRSA by subjecting them to susceptibil-
ity testing against vancomycin (Duchefa). The standard
strains of Staphylococcus aureus of National Collection of
Industrial Bacteria (NCIB) and American Typed Culture
Collection (ATCC) were obtained from culture collection
of Prof David Akinpelu, Department of Microbiology,
Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
The inoculum of the test isolates were prepared using
the colony suspension method as described by European
Committee for Antimicrobial Susceptibility Testing
(EUCAST) (2000). The inoculum were standardized
using 0.5 McFarland standards.
Preparation of plant materials and extraction
Fresh stem bark of Chrysophyllum albidium used for
this study was collected from Opa Village, Ile Ife
(7.4667° N, 4.5667° E), Osun State, Nigeria in April,
2014. The plant sample was identified in Herbarium of
Department of Botany, Obafemi Awolowo University,
Ile Ife, Osun State, Nigeria. Voucher specimen of the plant
sample was prepared (Voucher Number IFE-17419) and
deposited for reference purposes. The plant sample was air-
dried until a constant weight was obtained. The dried stem
bark was ground into powder using a mill (CHRISTY
LABMILL, Christy and Norris Ltd; Process Engineers,
Chelmsford, England), the powdered material was
stored in an air-tight container for further use.
Exactly 1500 g of powdered sample was soaked in
solution of methanol and sterile distilled water (3:2)
(v/v) for 96 h. The mixture was regularly agitated
throughout the period. The mixture was filtered into a
clean flask and the filtrate collected was concentrated
in vacuo in rotary evaporator to expel the methanol
from the aliquot. The aqueous part collected was ly-
ophilized to obtain crude extract of the plant. The
yield was noted and has dark brown colour.
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Test for phytochemical compounds present in C. albidum
extract
The phytochemical analysis of the extract was done using
Trease and Evans [20] and Harborne [21] methods. The
test include determination of the presence of tannins,
alkaloids, flavonoids, saponins, steroids, reducing sugars
and terpenoids in the extract.
Fractionation of the crude extract from C. albidium stem bark
The crude extract was fractionalized using different organic
solvents in order of their polarity. The solvent used are n-
hexane, chloroform, ethyl acetate and n-butanol in that
order. The yield obtained for each fraction was noted and
kept in an air-tight container for further use.
The antibiograms of the fractions obtained from the crude
extract against the test isolates
The antibiogram of the fractions was determined using
Akinpelu and Kolawole method [22]. The test isolates
were re-activated in nutrient broth for 18 h before use.
Exactly 0.1 mL of the standardized test isolates was
transferred into molten Mueller-Hinton agar medium at
40 °C, thoroughly mixed and then poured into a sterile
Petri dish. The plates were allowed to set and wells were
bored into the medium with the aid of a sterile 6 mm
cork borer. These wells were then filled up with the sus-
pension of the fractions at a concentration of 10 mg/mL.
Streptomycin and ampicillin each at a concentration of
1 mg/mL were used as positive control, while sterile dis-
tilled water in separate wells were used as negative con-
trol. The plates were allowed to stand on the laboratory
bench for 1 h to allow proper in-flow of the extract into
the medium. The plates were later incubated at 37 °C
for 24 h, after which they were observed for zones of in-
hibition which indicates susceptibility of the test isolates
to the extract.
The minimum inhibitory concentrations (MIC) of the
fractions against the test isolates
The MIC of the fractions against the test isolates was de-
termined using EUCAST [23] method. Dilution of the
fractions ranging between 0.313 and 5.00 mg/mL were
prepared and incorporated into molten nutrient agar at
45 °C and poured into sterile plates. The plates were
allowed to set and left on the laboratory bench overnight
to ascertain of non-contaminant in the prepared plates.
The plates were then inoculated with the standardized
inoculum of the test isolates by streaking across the
plate surface. These plates were incubated aerobically at
37 °C for 48 h and observed for any growth. The MIC
was taken as the lowest concentration of the extract that
inhibited the growth of the test isolates.
The minimum bactericidal concentration (MBC) of the
fractions against the test isolates
The MBC of the fractions against the test isolates was de-
termined using Spencer [24] and Okore [25] methods with
some modifications. Samples were taken from plates with
no visible growth in MIC assay and sub-cultured onto
freshly prepared nutrient agar plates and incubated at 37 °C
for 72 h. The MBC was taken as the concentration of the
extract that did not show any bacterial growth on fresh
nutrient agar plates.
Determination of rate of kill of the test isolates by the
fractions
The assay of the rate of kill of the test isolates was deter-
mined using Odenholt method [26] with some modifica-
tion. Culture of the test isolates was first standardized to
approximately 106 cfu/mL before use. Exactly 0.5 mL of
the standardized suspension of the culture was added to
4.5 mL of different concentrations of the fraction relative
to MIC. These were held at room temperature over a
period of 2 h to determine the killing rate. Exactly 0.5 mL
of the standardized suspension of the culture was added
to 4.5 mL of different concentrations of the fraction rela-
tive to MIC. These were held at room temperature over a
period of 2 h to determine the killing rate. A volume of
0.5 mL of each suspension was withdrawn at time inter-
vals and transferred to 4.5 mL of recovery medium con-
taining 3 % “Tween 80” to shake off the effect of the
extract carry-overs from the test isolates. The suspension
was then serially diluted and plated for viable counts. The
plates were incubated at 37 °C for 48 h before reading.
Control plates containing the test cells without the extract
were set up along with the experimental. The emergent
bacterial colonies were counted and compared with the
counts of the culture control.
Determination of potassium ion leakage from the test
isolates by the fractions
Exactly 50 mL of harvested and washed cells (OD470nm =
1.5) were placed in a clean 100 mL beaker which was
magnetically stirred. A volume (5 mL) of ionic strength
adjustment buffer (ISAB; 18.37 g of tetraethylammonium
chloride in deionized water and made up to 100 mL) was
added to the beaker. This ensured that the background
ionic strength of all solutions was kept constant. The
potassium ion sensing electrode (Qualiprobe QSE 314,
EDT Instruments Waldershare Park, Dover, UK) and its
reference electrode (Qualiprobe double junction reference
electrode E8092, EDT Instruments) were placed into the
cell suspension. The potential difference (mV) derived by
the electrodes was measured using a Whatmann PHA 220
pH/mV meter (Whatmann Maidstone, UK). Bacterial cells
were treated with various concentrations of the fraction of
the plant extract relative to the MIC. The potassium efflux
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from the cells in the suspension was measured at time
intervals over 2 h as a potential difference in mV. These
values were converted to concentrations of K+ ions (M) by
reference to a conversion graph, which had been con-
structed earlier using KCl standard solutions. The concen-
tration of K+ ions released was plotted against time.
Determination of nucleotides leakage from the test
isolates by the fractions
The leakage of nucleotides from the test cells was deter-
mined using Heipieper method [27]. Washed cells of
18 h old test isolates was standardized (approximately
106 cfu/mL) and treated with different concentrations of
the fractions relative to the MIC at various contact time
intervals over 2 h. Each suspension was centrifuged at
10,000 rpm and decanted. Wavelength of the super-
natant collected was determined at 260nm to quantify
the amount of nucleotide leaked by comparing with the
standard curve already plotted (A range of concentration
from 0.5 to 5 μM of dNTP mix (dA, dC, dG, dT)
(INQABA© Biotech, Pretoria, South Africa) was pre-
pared in TE buffer and used to generate the standard
curve). The blank constitute sterile distilled water inocu-
lated with the test isolates.
Statistics and data processing
All experiments were done in triplicates. Data was analysed
for a 4 × 4 Latin square design with the statistical program
using the GLM model (Statistical Analysis Systems, SAS
Institute, Cary, NC, USA, 2001). Results were contrasted
with negative and a positive control. The means of the
values was compared using independent t test of signifi-
cance (p < 0.05).
Results
Five fractions were obtained from the crude extract of C.
albidium and they are n-butanol, n-hexane, chloroform,
ethyl acetate and aqueous fractions. Two of the fractions
(n-butanol and n-hexane) exhibited antimicrobial activities
against the test isolates while other fractions were not ac-
tive against the test isolates of VRSA. The zones of inhib-
ition exhibited by both n-butanol and n-hexane fractions
against the test isolates ranged between 10 and 16 mm.
The zone of inhibition exhibited by n-butanol against S.
aureus (NCIB 8588) was 17 mm while that exhibited
against S. aureus (ATCC 6538) was 19 mm. On the other
hand, zones of inhibition observed for n-hexane fraction
against S. aureus (NCIB 8588) was 16 mm and for S.
aureus (ATCC 6538) was 18 mm (Table 1). Strepto-
mycin and ampicillin inhibited 33 out of 37 and 27 out
of 37 test isolate respectively. The zones of inhibition
exhibited by streptomycin against the test isolates ranged
between 14 and 24 mm. On the other hand, ampicillin ex-
hibited between 12 and 23 mm zones of inhibition against
the test isolates. Overall, the two active fractions com-
pared favourably with the two standard antibiotics used as
positive control for this study.
The MIC and MBC exhibited by both n-butanol and
n-hexane fractions against the test isolates were also
determined. The MIC exhibited by n-butanol fraction
ranged between 0.63 and 5.00 mg/mL while that of n-
hexane was between the same range with that of n-butanol.
The minimum bactericidal effects showed against the
test isolates by both fractions ranged between 1.25 and
10.00 mg/mL. From all indications both n-butanol and
n-hexane fractions exhibited equal antimicrobial activ-
ities against the test isolates (Table 2).
The phytochemical compounds present in the extract
were also investigated. The extract revealed the presence
of tannins, alkaloids, flavonoids, saponins, steroids, redu-
cing sugars and terpenoids (Table 3).
The bactericidal potentials of the two fractions were
determined on the test isolates by assaying for the killing
rate, potassium ion leakage and leakage of nucleotides.
Figure 1a shows the extent and killing rate of the test
isolates by n-hexane fraction. At a concentration of 1 ×
MIC after 15 min of contact time of the isolates with the
fraction, 44.5 % of the test isolates was killed and this
rose to 55.5 % at 30 min of contact time. At 60 min con-
tact time the population of the test isolates killed was
61.3 % while the population rose to 73.0 % at 90 min
contact time. Finally, at 120 min contact time 87.7 % of
the test isolates were killed. This monophasic effects
were also observed when the n-hexane fraction concen-
trations were increased to 2 ×MIC and 3 ×MIC. Finally
100 % cells killing was achieved at 3 ×MIC concentra-
tion after 120 min of contact time of the test cells with
the fraction (Fig. 1a). The same trend of reactions were
observed when the test isolates were subjected to n-
butanol fraction (Fig. 1b). The rate at which the test cells
were killed increases with the concentrations as well as
increase in contact time. This is also an indication of
monophasic effects. Thus, the bactericidal effects of both
n-hexane and n-butanol were through cell membrane
disruption as indicated in the experiment.
Figure 2a shows the effect of n-hexane fraction on
potassium ion leakage from the test cells at concentra-
tions of 1 ×MIC, 2 ×MIC and 3 ×MIC. The quantity of
potassium ion that got leaked out of the test cells at
1 ×MIC after 15 min contact time of the cells with the
fraction was 24.17 μg/mL. When the contact time reached
90 min at the same concentration, the quantity of potas-
sium ion leaked out of the cells reached 62.23 μg/mL and
about 72.63 μg/mL was observed at 120 min of contact
time (Fig. 2a). This monophasic effects were also observed
for n-butanol fraction reactions with the test cells (Fig. 2b).
Increase in concentrations and contact time resulted in in-
crease in percentage of the test cells killed. For example,
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at 1 ×MIC and 120 min contact time the quantity of po-
tassium ion leaked out of the test cells was 67.83 μg/mL.
At concentrations of 2 ×MIC and 3 ×MIC and contact
time of 120 min, the quantities of potassium ion leaked
out of the test cells were 83.59 and 103.0 μg/mL respect-
ively (Fig. 2b).
The extent and damaged done to the test cells mem-
brane was also observed through nucleotide leakage
Table 1 Sensitivity patterns exhibited by fractions obtained from Chrysophyllum albidum against the bacterial isolates
Zones of inhibition (mm)a
Bacterial isolates BUT (10 mg/ml) AQU (10 mg/ml) n-HEX (10 mg/ml) CHL (10 mg/ml) ETHYL (10 mg/ml) STREP (1 mg/ml) AMP (1 mg/ml)
VRSA 1 11 ± 1.00 0 12.00 0 0 19 ± 1.41 0
VRSA 2 13 ± 1.41 0 14 ± 0.71 0 0 14 ± 0.58 0
VRSA 3 15 ± 0.71 0 13 ± 1.41 0 0 20 ± 0.71 17.00
VRSA 4 14.00 0 13 ± 1.00 0 0 23 ± 1.00 18 ± 0.71
VRSA 5 15 ± 0.58 0 12 ± 0.58 0 0 17 ± 1.20 16 ± 1.41
VRSA 6 15 ± 1.41 0 13 ± 1.41 0 0 18 ± 1.41 18 ± 1.00
VRSA 7 12.00 0 15 ± 1.00 0 0 20.00 20 ± 1.41
VRSA 8 11 ± 0.56 0 10.00 0 0 18.00 0
VRSA 9 11 ± 0.71 0 13 ± 0.56 0 0 16 ± 0.71 23 ± 0.56
VRSA 10 13 ± 1.20 0 14 ± 0.71 0 0 0 18.00
VRSA 11 11 ± 1.41 0 11 ± 0.54 0 0 0 16 ± 0.58
VRSA 12 0 0 0 0 0 17.00 0
VRSA 13 12 ± 1.00 0 14 ± 1.20 0 0 15.00 13 ± 0.71
VRSA 14 10.00 0 11 ± 0.56 0 0 18.00 0
VRSA 15 0 0 0 0 0 16 ± 0.58 0
VRSA 16 11 ± 1.41 0 13 ± 1.00 0 0 19.00 22 ± 0.71
VRSA 17 14.00 0 16.00 0 0 21 ± 0.56 13 ± 0.52
VRSA 18 13 ± 0.52 0 15 ± 0.52 0 0 17.00 23.00
VRSA 19 13 ± 1.00 0 12.00 0 0 19.00 0
VRSA 20 13 ± 0.54 0 15 ± 0.54 0 0 0 18.00
VRSA 21 13 ± 1.00 0 14.00 0 0 20 ± 1.00 15 ± 1.20
VRSA 22 11 ± 0.71 0 13 ± 1.41 0 0 22.00 19 ± 0.54
VRSA 23 13 ± 1.41 0 12.00 0 0 21 ± 0.54 17 ± 1.00
VRSA 24 10.00 0 14 ± 0.71 0 0 23.00 20.00
VRSA 25 11 ± 0.56 0 10.00 0 0 21.00 16 ± 1.41
VRSA 26 12.00 0 16 ± 1.00 0 0 23 ± 1.20 0
VRSA 27 15 ± 1.20 0 15 ± 1.20 0 0 22.00 19.00
VRSA 28 13 ± 0.71 0 14.00 0 0 20.00 0
VRSA 29 12 ± 0.58 0 12 ± 0.71 0 0 0 13 ± 0.54
VRSA 30 14.00 0 15 ± 0.58 0 0 24.00 20.00
VRSA 31 14 ± 0.71 0 11 ± 1.41 0 0 21.00 15.00
VRSA 32 10.00 0 12 ± 1.00 0 0 19.00 16.00
VRSA 33 13 ± 0.54 0 12.00 0 0 20.00 0
VRSA 34 11 ± 1.00 0 12 ± 0.71 0 0 19 ± 0.71 20.00
VRSA 35 16.00 0 15 ± 0.56 0 0 16.00 12.00
VRSA 36 17 ± 0.71 0 16 ± 0.52 0 0 23 ± 0.58 21.00 ± 0.71
VRSA 37 19 ± 1.20 0 18 ± 1.00 0 0 24 ± 0.70 22 ± 1.00
Key: BUT = Butanol fraction, AQU = Aqueous fraction, n-HEX = n-Hexane Fraction, CHL = Chloroform fraction, ETHYL = Ethy1 acetate fraction, STREP = Streptomycin
and AMP = Ampicillin, a = Mean of three replicates, VRSA = Vancomycin resistant Staphylococcus aureus (Clinical strains), VRSA 36 = Staphylococcus aureus (NCIB
8588), VRSA 37 = Staphylococcus aureus (ATCC 6538)
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(Fig. 3). The two fractions exhibited appreciable nucleo-
tide leakage as observed in the results. When the test
cells were subjected the effects of n-hexane fraction at a
concentration of 1 ×MIC and at 15 min contact time
the quantity of nucleotides leaked from the cells was
0.43 μg/mL. At 30 min contact time, the quantity leaked
increased to 0.57 μg/mL and got to 0.75 μg/mL after
60 min of contact time. There was an increase in the quan-
tity of nucleotides leaked out of the cells to 0.93 μg/mL
when the contact time was increased to 120 min. The same
trend of nucleotide leakage from the test cells was observed
when the concentrations of n-hexane fraction were in-
creased by 2 ×MIC and 3 ×MIC (Fig. 3a). The effects of n-
butanol fraction against the test isolates was also observed
as shown in Fig. 3b. There was an increase in the quantity
of nucleotides leaked from the cells as the concentrations
and contact time increased. For example, at 1 ×MIC, 2 ×
MIC and 3 ×MIC concentrations after 120 min of contact
time, the quantities of nucleotides leaked from the cells
were 1.03, 1.46 and 2.24 μg/mL respectively (Fig. 3b).
Discussion
The antimicrobial potentials of stem bark extract of
Chrysophyllum albidium were investigated on various
isolates of vancomycin resistant S. aureus isolated from
clinical samples along with two typed cultures, one of
NCIB and the other of ATCC. Staphylococcus aureus is
a pathogen and is responsible for various ailments in
humans and animals. This organism has developed re-
sistant to many antibiotics used as therapy against infec-
tions caused by it. Methicillin was later chosen as a drug
of choice for the treatment of infections caused by this
pathogen but later developed resistant to it [6, 7]. Later,
vancomycin was adopted to combat the activities of S.
aureus and this drug is no longer showing potency
towards the treatment of infection caused by this patho-
gen [8]. The results obtained from our studies on frac-
tions obtained from C. albidium stem bark extract
showed that the extract exhibited high antibacterial ac-
tivities towards various isolates of vancomycin resistant
Table 2 The minimum inhibitory and bactericidal concentrations
exhibited by the butanol and n-hexane fractions against susceptible
bacterial isolates
Butanol fraction n-Hexane fraction
Bacterial
isolates
MIC (mg/ml) MBC (mg/ml) MIC (mg/ml) MBC (mg/ml)
VRSA 1 5.00 10.00 2.50 5.00
VRSA 2 ND ND 5.00 10.00
VRSA 3 1.25 2.50 1.25 2.50
VRSA 4 1.25 2.50 1.25 2.50
VRSA 5 2.50 5.00 5.00 10.00
VRSA 6 1.25 2.50 0.63 1.25
VRSA 7 2.50 5.00 1.25 2.50
VRSA 8 ND ND 5.00 10.00
VRSA 9 5.00 10.00 ND ND
VRSA 10 5.00 10.00 1.25 2.50
VRSA 11 1.25 2.50 2.50 5.00
VRSA 12 ND ND ND ND
VRSA 13 ND ND ND ND
VRSA 14 5.00 10.00 ND ND
VRSA 15 ND ND ND ND
VRSA 16 1.25 2.50 1.25 2.50
VRSA 17 1.25 2.50 0.63 1.25
VRSA 18 ND ND 1.25 2.50
VRSA 19 5.00 10.00 ND ND
VRSA 20 5.00 10.00 2.50 5.00
VRSA 21 2.50 5.00 ND ND
VRSA 22 ND ND ND ND
VRSA 23 1.25 2.50 1.25 2.50
VRSA 24 1.25 2.50 0.63 1.25
VRSA 25 2.50 5.00 2.50 5.00
VRSA 26 1.25 2.50 1.25 2.50
VRSA 27 2.50 5.00 2.50 5.00
VRSA 28 1.25 2.50 0.63 1.25
VRSA 29 1.25 2.50 5.00 10.00
VRSA 30 2.50 5.00 5.00 10.00
VRSA 31 0.63 1.25 0.63 1.25
VRSA 32 1.25 2.50 2.50 5.00
VRSA 33 2.50 5.00 0.63 1.25
VRSA 34 1.25 2.50 1.25 2.50
VRSA 35 ND ND ND ND
VRSA 36 0.63 1.25 1.25 2.50
VRSA 37 1.25 2.50 2.50 5.00
KEY: VRSA = Vancomycin resistant Staphylococcus aureus (Clinical strains),
MIC = Minimum Inhibitory Concentration, MBC =Minimum Bactericidal
Concentration, VRSA 36 = Staphylococcus aureus (NCIB 8588), VRSA
37 = Staphylococcus aureus (ATCC 6538), ND = Not Done
Table 3 Preliminary phytochemical compounds obtained from
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S. aureus used for this studies. Fractions obtained from
this extract compared favourably with the two standard
antibiotics–ampicillin and streptomycin used as positive
controls. This is an indication that C. albidium stem
bark extract could serve as a remedy to combat the in-
fections caused by VRSA along with other pathogens
that have now developed resistance to various antibiotics
now in circulation used as therapy against infections
caused by microorganisms. Chrysophyllum albidium is
used among many tribes in West Africa for the treat-
ment of various infections caused by microorganisms.
Extracts obtained from C. albidium exhibited the presence
of phytochemicals which include flavonoids, tannins, sa-
ponins, alkaloids, steroids, reducing sugars and terpenoids.
These phytochemicals contributed to the bioactive poten-
tials of this plant. Phytochemicals have been reported to
be biologically active [19] and thus contributed to the
antimicrobial activities of this plant. These facts supported
the usefulness of C. albidium in folklore remedies. The
natural products and phytochemical compounds present
in this plant can be exploited for the development of novel
bioactive compounds for the treatment of infections
caused by VRSA and other pathogens that are now be-
coming resistant to antibiotics.
Mode of action of n-hexane and n-butanol fractions
from crude extract of C. albidium were also investigated
through rate of killing, leakages of potassium ions and
nucleotides from the test cells. Chrysophyllum albidium
extract exerted a biocidal effects on the test cells and
this might have been contributed by the phytochemicals
present in this plant’s extract. The killing rate exhibited
by both n-hexane and n-butanol showed a 100 % kill of
the test cells at a concentration of 3 ×MIC within the
shortest time of 120 min of the contact time (Fig. 1).
Fig. 1 The extent and the rate of killing of test cells by n- hexane (a) and butanol (b) fractions at 1 × MIC ( ), 2 × MIC ( ), 3 × MIC
( ) and control ( ). Each point represents the log10 of mean survival of bacterial cells at a particular time interval in the presence of
the fraction
A B
Fig. 2 The effect of the n- hexane (a) and butanol (b) fractions on potassium ion leakage from test cells at 1 × MIC ( ), 2 × MIC ( ), 3 ×
MIC ( ) and control ( ). Each point represents the amount of potassium ions leaked (μg/ml) from the cells at a particular time interval
in the presence of the fraction
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The ability of plant extract to eliminate or kill organisms
at the shortest period of time is generally accepted defin-
ition of bactericidal activity in antibiotics [28]. These
fractions also exhibited appreciable potassium ions and
nucleotides leakage from the test cells which also led to
the death of the organisms (Figs. 2 and 3). Leakage of
potassium ions from bacterial cell could lead to deactiva-
tion of important enzymes required for cell metabolism
and this effects could be lethal on the cells [29]. Potas-
sium is the major monovalent intracellular cations in
cells, and its uptake is essential for all living organisms
[30]. Potassium has many key functions within bacterial
cells and this include activation of intracellular enzymes.
It also act as an intracellular second messenger and in-
volved in the maintenance of a constant internal pH and
membrane potential [31]. In addition, potassium plays
an important function as an osmotic solute. Potassium
ions transport is a critical determinant of growth and
survival through its role in regulating cytoplasmic pH
and cell turgor [32, 33]. Thus leakage of potassium ions
from bacterial cells will have a serious effect on such
cells as this leads to their death. Leakage of intracellular
materials from the cells is an indication of damage to
the cell membrane. Thus permeability of the cytoplasmic
membrane will lead to the loss of cellular matters and
consequently results in cell death [32]. From our results
in this study, C. albidium extract might have caused
disruption in cell membrane of VRSA used for this
study and thus led to their death. This observation was
also noted by [33]) in their work on Candida albicans
and C. krusei.
Conclusion
The bactericidal activities exhibited by C. albidium extract
against VRSA used in this study revealed a significant
therapeutic potential of this plant and supported its useful-
ness in folklore remedies for the management of infections
caused by pathogens. The ability of the plant extract frac-
tions obtained from C. albidium to kill VRSA in this study
at low concentration and minimal contact time has estab-
lished the potential of the plant as a template for future
drugs that could be formulated to combat infections
caused by VRSA; such drug would be useful in combating
the menace of VRSAs in human and animal health.
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